Glucagon shortage extended

Emergency diabetes treatment shortage to continue for another month  Novo Nordisk Pharmaceuticals warns a critical shortage of its GlucaGen HypoKit (glucagon) will continue until 31 October.  The company had initially expected supplies of the medication to return to normal levels by 30 September, when it originally notified the Therapeutic Goods Administration (TGA) of manufacturing delays